The Cigna Group stock at EUR 269.80, up 1.43% premarket
Published on 11/16/2026 at 08:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Investors Should Watch
- The Cigna Group is scheduled to release third-quarter 2026 results on Thursday, November 19.
- Management's 2026 adjusted earnings floor stands at USD 30.60 per share after the November 5 update.
- The business combines health benefits with pharmacy services, keeping Evernorth performance central to the next earnings readout.
The Cigna Group stock traded at EUR 269.80 on Lang & Schwarz at 08:31 CET on Monday, November 16, 1.43 percent above the Xetra close of Friday, November 13.
The move comes as investors look toward the company's next quarterly update. The Cigna Group is scheduled to release third-quarter 2026 results before the US market opens on Thursday, November 19, according to the Cigna newsroom.
Guidance Sets The Earnings Focus
The upcoming report follows the company's November 5 release, which lifted the minimum 2026 adjusted earnings outlook to USD 30.60 per share. That guidance gives investors a reference point for assessing quarterly execution and the outlook for the remainder of the year.
The company operates across health benefits and pharmacy services. Its Cigna Healthcare and Evernorth businesses expose results to medical-cost trends, prescription-drug economics and contract performance. Investors will therefore be watching both quarterly earnings and management's commentary on pharmacy-benefit pressures.
US equities are tracked through the S&P 500.
